Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Activated choline metabolism is a hallmark of carcinogenesis and tumor progression, which leads to elevated levels of phosphocholine and glycerophosphocholine in all types of cancer tested so far. Magnetic resonance spectroscopy applications have played a key role in detecting these elevated choline phospholipid metabolites. To date, the majority of cancer‐related studies have focused on phosphocholine and the Kennedy pathway, which constitutes the biosynthesis pathway for membrane phosphatidylcholine. Fewer and more recent studies have reported on the importance of glycerophosphocholine in cancer. In this review article, we summarize the recent literature on glycerophosphocholine metabolism with respect to its cancer biology and its detection by magnetic resonance spectroscopy applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974 · cited 1×
“This intracellular domain phosphorylation of receptors triggers downstream signaling pathways that result in cell proliferation and migration.(153,154) Members of the EGFR family are EGFR/HER1, HER2, HER3 and HER4.”
BackgroundFundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013
Kurhanewicz, J., Vigneron, D. B., Brindle, K., Chekmenev, E. Y., Comment, A., Cunningham, C. H., DeBerardinis, R. J., Green, G. G., Leach, M. O., Rajan, S. S., et al. (2011) · Neoplasia · doi:10.1593/neo.101102 · Cited by 681
Kadamur, G., & Ross, E. M. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183750 · Cited by 610 · cited 1×
“In mammalian systems, only cPLA2α, cPLA2β, cPLA2γ and cPLA2δ are expressed.(52,55) All members of the PLA2 superfamily catalyze the hydrolysis of fatty acids at the sn‐2 position of glycerophospholipids, which produces free fatty acid and lyso‐phospholipid (Figure 3A).”
BackgroundBreast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
Thomas, R. J., Guise, T. A., Yin, J. J., Elliott, J., Horwood, N. J., Martin, T. J., & Gillespie, M. T. (1999) · Endocrinology · doi:10.1210/endo.140.10.7037 · Cited by 536
GDE2 Promotes Neurogenesis by Glycosylphosphatidylinositol-Anchor Cleavage of RECK
Park, S., Lee, C., Sabharwal, P., Zhang, M., Meyers, C. L. F., & Sockanathan, S. (2013) · Science · doi:10.1126/science.1231921 · Cited by 118 · cited 1×
“Additionally, GDPD5 (GDE2) has a function in neuronal differentiation, as the catalytic activity of GDPD5 (GDE2) induced motor neuron differentiation(98) through autonomous cleavage of a GPI anchor from the RECK protein located in the neighboring cells.(99) A recent report has shown that GDPD5 (GDE2) induced neuroblas…”
BackgroundTransmembrane Protein GDE2 Induces Motor Neuron Differentiation in Vivo
Rao, M., & Sockanathan, S. (2005) · Science · doi:10.1126/science.1117156 · Cited by 83
Research works printed but not linked: 330
- 10.1038/nature12626 · DOI · Paper page
- 10.1097/PPO.0000000000000127 · DOI
- 10.1038/nrc1782 · DOI · Paper page
- 10.18632/oncotarget.13907 · DOI · Paper page
- 10.1016/j.redox.2017.04.018 · DOI · Paper page
- 10.1016/j.cell.2011.02.013 · DOI · Paper page
- 10.1007/BF01114871 · DOI
- Daly PF, 1987, Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy, J Biol Chem., 262, 14875, 10.1016/S0021-9258(18)48107-0 · DOI · Paper page
- Aboagye EO, 1999, Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells, Cancer Res., 59, 80
- 10.1002/jmri.10181 · DOI · Paper page
- 10.1002/ijc.23552 · doi:10.1002/ijc.23552
- 10.1002/mrm.10654 · doi:10.1002/mrm.10654
- 10.1155/2004/424395 · DOI
- 10.1371/journal.pone.0180263 · DOI
- 10.1038/nrc3162 · DOI · Paper page
- 10.1002/jmri.10427 · DOI · Paper page
- 10.1148/radiol.2332031285 · DOI
- 10.1038/sj.bjc.6602948 · DOI
- 10.1148/radiol.2512080553 · DOI
- 10.1111/j.1471-0528.2008.02007.x · DOI
- 10.1002/jmri.10172 · DOI
- Ackerstaff E, 2001, Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells, Cancer Res., 61, 3599
- 10.1007/s10910-016-0694-8 · DOI
- 10.1002/nbm.3097 · DOI
- 10.1016/j.ijrobp.2012.01.020 · doi:10.1016/j.ijrobp.2012.01.020
- 10.1016/S0730-725X(01)00225-9 · doi:10.1016/s0730-725x(01)00225-9
- 10.1158/0008-5472.CAN-13-2409 · DOI
- 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U · DOI · Paper page
- 10.1158/0008-5472.CAN-05-1146 · DOI · Paper page
- 10.1002/nbm.1762 · DOI
- 10.1016/j.mric.2013.04.008 · doi:10.1016/j.mric.2013.04.008
- 10.1002/jmri.25560 · doi:10.1002/jmri.25560
- 10.1002/nbm.3684 · doi:10.1002/nbm.3684
- 10.1021/acs.biochem.7b01257 · doi:10.1021/acs.biochem.7b01257
- 10.1038/onc.2011.332 · DOI
- 10.1038/oncsis.2013.2 · doi:10.1038/oncsis.2013.2
- 10.1002/nbm.3429 · DOI
- 10.1016/0968-0004(88)90145-4 · doi:10.1016/0968-0004(88)90145-4
- 10.1016/S0021-9258(19)50785-2 · DOI · Paper page
- Cuadrado A, 1993, Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors, Oncogene., 8, 2959
- 10.1002/jcb.240570114 · DOI
- Price BD, 1989, Stimulation of phosphatidylcholine hydrolysis, diacylglycerol release, and arachidonic acid production by oncogenic ras is a consequence of protein kinase C activation, J Biol Chem., 264, 16638, 10.1016/S0021-9258(19)84753-1 · DOI
- 10.1073/pnas.83.18.6785 · DOI
- 10.1016/0005-2760(88)90114-2 · DOI
- 10.1007/BF02532834 · DOI
- 10.1074/jbc.272.31.19214 · doi:10.1074/jbc.272.31.19214
- 10.1002/nbm.2766 · DOI
- 10.1111/febs.12699 · DOI
- 10.1074/jbc.M110.106708 · DOI
- 10.3390/ijms12010588 · DOI · Paper page
- 10.1007/s11805-011-0562-z · DOI
- 10.1007/s10557-008-6132-9 · DOI · Paper page
- Kita Y, 1761, Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s, Biochim Biophys Acta Mol Cell Biol Lipids., 2006, 1317
- 10.1038/nrc2809 · DOI · Paper page
- 10.1194/jlr.R057588 · DOI · Paper page
- Bocca C, 2014, COX2 inhibitor NS398 reduces HT‐29 cell invasiveness by modulating signaling pathways mediated by egfr and HIF1‐α, Anticancer Res., 34, 1793
- Nakanishi M, 1761, Roles of cPLA2α and arachidonic acid in cancer, Biochim Biophys Acta., 2006, 1335
- 10.1210/me.2009-0293 · DOI
- 10.1038/sj.bjc.6606025 · DOI
- 10.1007/s12017-009-8092-z · DOI · Paper page
- 10.1074/jbc.274.13.8823 · DOI · Paper page
- 10.1002/jlb.65.3.330 · DOI · Paper page
- 10.1371/journal.pone.0045025 · DOI
- 10.1007/s00428-012-1227-x · DOI
- 10.1007/s10585-011-9404-x · DOI
- 10.1038/37622 · DOI · Paper page
- 10.2174/1568009615666150706103234 · DOI
- 10.1074/jbc.M807282200 · DOI
- 10.1016/j.canlet.2011.02.015 · doi:10.1016/j.canlet.2011.02.015
- Kisslov L, 1821, HT‐29 human colon cancer cell proliferation is regulated by cytosolic phospholipase A2α dependent PGE2 via both PKA and PKB pathways, Biochim Biophys Acta Mol Cell Biol Lipids., 2012, 1224
- 10.1016/j.plefa.2009.11.005 · DOI
- 10.1242/jcs.00446 · DOI
- 10.1038/cddis.2017.152 · DOI
- 10.1158/1078-0432.CCR-08-0566 · DOI
- 10.1093/jnci/djq290 · DOI
- 10.1074/jbc.274.24.17063 · DOI
- 10.1186/1471-2407-10-433 · DOI · Paper page
- 10.1021/bc200242v · doi:10.1021/bc200242v
- 10.1021/bc100271v · doi:10.1021/bc100271v
- 10.1021/acs.bioconjchem.5b00417 · DOI
- 10.1016/0005-2736(80)90574-X · DOI · Paper page
- 10.1016/j.biochi.2006.09.021 · DOI · Paper page
- 10.1016/S1388-1981(99)00063-3 · DOI
- 10.1042/bj3080551 · doi:10.1042/bj3080551
- 10.1042/bj2880831 · doi:10.1042/bj2880831
- 10.1073/pnas.73.5.1586 · doi:10.1073/pnas.73.5.1586
- Kelly RA, 1986, Identification of NaK‐ATPase inhibitors in human plasma as nonesterified fatty acids and lysophospholipids, J Biol Chem., 261, 11704, 10.1016/S0021-9258(18)67301-6 · DOI · Paper page
- 10.1186/s13071-017-2228-z · DOI
- Larson TJ, 1983, Periplasmic glycerophosphodiester phosphodiesterase of Escherichia coli , a new enzyme of the glp regulon, J Biol Chem., 258, 5428, 10.1016/S0021-9258(20)81908-5 · DOI · Paper page
- 10.1042/bj0620689 · doi:10.1042/bj0620689
- 10.1073/pnas.88.17.7820 · DOI
- 10.1073/pnas.0805496105 · DOI
- 10.1073/pnas.1117654109 · DOI
- 10.1074/jbc.M114.614537 · DOI
- 10.1016/j.ccell.2016.08.016 · DOI
- 10.18632/oncotarget.14233 · DOI
- 10.1002/nbm.3106 · DOI
- 10.1002/nbm.3573 · DOI
- 10.1016/j.neo.2017.05.004 · doi:10.1016/j.neo.2017.05.004
- 10.1128/MCB.9.1.325 · DOI
- 10.1038/sj.onc.1205144 · doi:10.1038/sj.onc.1205144
- 10.1080/10408360290795538 · DOI · Paper page
- 10.1016/S0092-8674(00)81764-X · DOI · Paper page
- 10.3390/cancers7030860 · DOI · Paper page
- 10.1101/cshperspect.a011254 · DOI · Paper page
- 10.7150/ijms.1.101 · DOI · Paper page
- Katz M, 1773, Regulation of MAPKs by growth factors and receptor tyrosine kinases, Biochim Biophys Acta., 2007, 1161
- 10.1038/358417a0 · DOI · Paper page
- 10.1074/jbc.M212803200 · DOI
- 10.1016/j.ctrv.2014.02.008 · DOI · Paper page
- 10.1096/fasebj.6.6.1312047 · DOI · Paper page
- 10.1634/theoncologist.8-6-531 · DOI · Paper page
- 10.1038/nrc3093 · DOI · Paper page
- 10.1016/0092-8674(87)90581-2 · DOI · Paper page
- 10.1210/er.20.3.321 · DOI
- 10.1126/science.1071884 · DOI · Paper page
- 10.1097/00001703-199906000-00003 · DOI
- 10.1186/bcr79 · DOI
- 10.1007/s00018-003-3222-5 · DOI
- 10.1126/science.1132509 · DOI
- 10.1186/1471-2407-10-629 · DOI
- 10.1158/0008-5472.CAN-09-3834 · DOI
- 10.1210/en.2009-1506 · DOI
- 10.1093/annonc/mdn291 · DOI · Paper page
- 10.1023/A:1023777013659 · DOI · Paper page
- 10.1073/pnas.0308319100 · DOI · Paper page
- 10.1016/j.steroids.2009.02.005 · DOI
- 10.1016/S0002-9440(10)64702-5 · DOI · Paper page
- 10.1016/j.ccr.2010.02.030 · DOI · Paper page
- 10.1530/rep.1.00189 · DOI · Paper page
- 10.1016/j.jmb.2016.06.020 · DOI · Paper page
- 10.1016/j.mce.2011.10.030 · DOI · Paper page
- 10.1210/me.2005-0242 · DOI · Paper page
- 10.1186/bcr452 · DOI · Paper page
- 10.1023/A:1015718406329 · DOI
- Frech MS, 2005, Deregulated estrogen receptor α expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ, Cancer Res., 65, 681, 10.1158/0008-5472.681.65.3 · doi:10.1158/0008-5472.681.65.3
- Medina D, 2003, Hormone dependence in premalignant mammary progression, Cancer Res., 63, 1067
- 10.1210/en.2008-1630 · DOI
- 10.1016/S0002-9440(10)65498-3 · DOI · Paper page
- 10.1073/pnas.0915148107 · DOI · Paper page
- 10.1007/s10549-014-3049-9 · DOI
- 10.1186/s13058-015-0538-7 · DOI · Paper page
- Bhatia P, 2005, Expression of receptor activator of Nuclear Factor‐κB ligand is inversely correlated with metastatic phenotype in breast carcinoma, Clin Cancer Res., 11, 162, 10.1158/1078-0432.162.11.1 · DOI
- 10.1158/1078-0432.CCR-06-1732 · DOI
- 10.1126/science.2470152 · DOI · Paper page
- 10.1186/bcr327 · DOI · Paper page
- 10.1155/2012/743193 · DOI · Paper page
- 10.1128/MCB.6.3.955 · DOI · Paper page
- 10.1128/MCB.6.5.1729 · DOI · Paper page
- 10.1126/science.3012781 · DOI · Paper page
- 10.1007/s10549-011-1606-z · DOI
- 10.1097/PDM.0b013e31818cbdb2 · DOI
- 10.1016/j.ejca.2005.11.012 · DOI
- 10.1007/s12282-007-0026-8 · doi:10.1007/s12282-007-0026-8
- 10.1038/sj.onc.1202091 · DOI
- Ramić S, 2013, Correlation of phosphorylated HER2 with clinicopathological characteristics and efficacy of trastuzumab treatment for breast cancer, Anticancer Res., 33, 2509
- 10.1021/pr9008783 · DOI
- 10.1038/nrc839 · DOI · Paper page
- 10.1128/MCB.01917-07 · DOI
- 10.1016/S0092-8674(00)81683-9 · DOI · Paper page
- 10.1016/S0065-230X(09)02001-6 · DOI · Paper page
- 10.1038/nrc969 · DOI · Paper page
- Bos JL, 1989, ras oncogenes in human cancer: A review, Cancer Res., 49, 4682
- 10.1016/S0962-8924(00)01740-2 · DOI · Paper page
- 10.1146/annurev.bi.62.070193.004223 · DOI · Paper page
- 10.1101/gad.11.19.2468 · DOI · Paper page
- Colicelli J, 2004, Human RAS superfamily proteins and related GTPases, Sci. STKE, 2004, 10.1126/stke.2502004re13 · DOI · Paper page
- 10.1074/jbc.M115.656710 · DOI
- 10.1016/S0304-419X(99)00007-4 · DOI
- 10.1016/0092-8674(90)90294-O · DOI · Paper page
- 10.1158/0008-5472.CAN-13-1750 · DOI
- 10.1038/369411a0 · DOI · Paper page
- 10.2174/1381612013397258 · DOI
- 10.1146/annurev.biochem.67.1.481 · DOI · Paper page
- 10.1016/j.ctrv.2003.07.007 · DOI · Paper page
- 10.1038/sj.onc.1209087 · DOI · Paper page
- 10.3389/fonc.2014.00064 · DOI · Paper page
- 10.3892/ijo.2016.3804 · DOI
- 10.1158/1535-7163.MCT-03-0220 · DOI
- 10.1002/nbm.1764 · DOI
- 10.2119/molmed.2011.00315 · doi:10.2119/molmed.2011.00315
- Singh S, 1799, Small molecule regulators of Rb–E2F pathway as modulators of transcription, Biochim Biophys Acta Gene Regul Mech., 2010, 788
- 10.1002/ijc.25181 · DOI
- Özcan S, 1799, Modulation of transcription factor function by O‐GlcNAc modification, Biochim Biophys Acta Gene Regul Mech., 2010, 353
- 10.1038/nature09607 · DOI
- 10.1371/journal.pgen.1002112 · DOI
- 10.1038/emboj.2011.159 · DOI
- 10.1200/jco.2011.29.15_suppl.599 · doi:10.1200/jco.2011.29.15_suppl.599
- 10.1158/0008-5472.CAN-09-1530 · DOI
- 10.1038/onc.2010.43 · DOI
- 10.1158/0008-5472.CAN-10-2330 · DOI · Paper page
- 10.1200/jco.2011.29.15_suppl.623 · doi:10.1200/jco.2011.29.15_suppl.623
- 10.1097/CAD.0b013e328341185b · DOI
- 10.1038/s41375-018-0117-x · DOI · Paper page
- 10.1158/0008-5472.CAN-10-2626 · DOI · Paper page
- 10.1016/j.tips.2012.01.005 · DOI · Paper page
- 10.1016/j.bcp.2010.03.026 · DOI · Paper page
- 10.1158/0008-5472.CAN-07-2678 · DOI
- 10.1593/neo.12858 · DOI
- 10.18632/oncotarget.24569 · DOI
200 of 330 shown
Cited by
Biomarker-Guided Imaging and AI-Augmented Diagnosis of Degenerative Joint Disease
Kumar, R., Sporn, K., Borole, A., Khanna, A., Gowda, C., Paladugu, P., Ngo, A., Jagadeesan, R., Zaman, N., & Tavakkoli, A. (2025) · Diagnostics · doi:10.3390/diagnostics15111418 · Cited by 13
Metadata
- Authors
- Sonkar, K., Ayyappan, V., Tressler, C. M., Adelaja, O., Cai, R., Cheng, M., & Glunde, K.
- Venue
- NMR in Biomedicine
- Publisher
- Wiley
- Published
- 2019-06-11
- Volume
- 32
- Issue
- 10
- Pages
- e4112-e4112
- ISSN
- 0952-3480 (ISSN-L)
- 1099-1492
- OpenAlex
- W2949840475
- Cited by
- 205
- References
- 8
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- National Cancer Institute (R01 CA213428, R01 CA213492)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer. https://app.cochat.ai/papers/10.1002/nbm.4112
- The paper
- Sonkar, K., Ayyappan, V., Tressler, C. M., Adelaja, O., Cai, R., Cheng, M., & Glunde, K. (2019). Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer. NMR in Biomedicine. https://doi.org/10.1002/nbm.4112
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.